NCT02018887View on ClinicalTrials.gov

A Study of LY2969822 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

LY2969822

Capsules administered orally

DRUG

Placebo

Capsules administered orally

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02018887 - A Study of LY2969822 in Healthy Participants | Biotech Hunter | Biotech Hunter